GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,000 | +12.5% | 458 | +17.1% | 0.01% | 0.0% |
| Q1 2019 | $16,000 | -84.8% | 391 | -85.7% | 0.01% | -87.2% |
| Q4 2018 | $105,000 | -20.5% | 2,740 | -16.7% | 0.05% | +9.3% |
| Q3 2018 | $132,000 | +3.1% | 3,291 | +3.3% | 0.04% | -18.9% |
| Q2 2018 | $128,000 | +23.1% | 3,186 | +20.1% | 0.05% | +71.0% |
| Q1 2018 | $104,000 | +300.0% | 2,652 | +258.4% | 0.03% | +287.5% |
| Q4 2017 | $26,000 | -69.8% | 740 | -65.3% | 0.01% | -77.1% |
| Q3 2017 | $86,000 | -36.3% | 2,130 | -35.5% | 0.04% | -37.5% |
| Q2 2017 | $135,000 | +10.7% | 3,301 | +16.1% | 0.06% | +5.7% |
| Q1 2017 | $122,000 | +269.7% | 2,844 | +233.0% | 0.05% | +278.6% |
| Q4 2016 | $33,000 | -38.9% | 854 | -31.5% | 0.01% | -54.8% |
| Q3 2016 | $54,000 | +1.9% | 1,246 | +5.6% | 0.03% | -6.1% |
| Q2 2016 | $53,000 | +71.0% | 1,180 | +55.5% | 0.03% | +26.9% |
| Q1 2016 | $31,000 | +63.2% | 759 | +59.1% | 0.03% | +36.8% |
| Q4 2015 | $19,000 | – | 477 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |